TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 122 filers reported holding TCR2 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $68,000 | -39.3% | 38,005 | -1.5% | 0.00% | -100.0% |
| Q2 2022 | $112,000 | -37.1% | 38,571 | -40.2% | 0.00% | -50.0% |
| Q1 2022 | $178,000 | -61.3% | 64,511 | -34.7% | 0.00% | -50.0% |
| Q4 2021 | $460,000 | -19.0% | 98,805 | +48.1% | 0.00% | -42.9% |
| Q3 2021 | $568,000 | +10.1% | 66,727 | +112.3% | 0.01% | +16.7% |
| Q2 2021 | $516,000 | -23.7% | 31,429 | +2.7% | 0.01% | -33.3% |
| Q1 2021 | $676,000 | +182.8% | 30,594 | +295.4% | 0.01% | +200.0% |
| Q4 2020 | $239,000 | – | 7,737 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $6,076,298 | 2.53% |
| MPM BioImpact LLC | 3,370,982 | $5,056,473 | 1.31% |
| TANG CAPITAL MANAGEMENT LLC | 3,399,745 | $5,099,618 | 0.76% |
| Newtyn Management, LLC | 1,015,920 | $1,523,880 | 0.30% |
| Artal Group S.A. | 750,000 | $1,125 | 0.07% |
| Long Focus Capital Management, LLC | 566,270 | $849,405 | 0.05% |
| Redmile Group, LLC | 658,336 | $987,504 | 0.04% |
| HARBOR CAPITAL ADVISORS, INC. | 67,642 | $101,463 | 0.03% |
| X-Square Capital, LLC | 31,720 | $48 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 71,046 | $106,569 | 0.02% |